PNPLA3 and metabolic dysfunction-associated steatotic liver disease: In this study, we analyzed the impact of combined genetic variants in PNPLA3, TM6SF2 and HSD17B13 on severity and phenotype of NAFLD/NASH in a large multi-center cohort of patients with biopsy-proven NAFLD.